WHETHER YOU ARE A STUDENT, A HEALTHCARE PROFESSIONAL OR NON-SPECIALIST


Eu2P OFFERS A WORLDWIDE TRAINING PROGRAMME THAT FITS YOUR NEEDS!


MEDICINES BENEFIT-RISK ASSESSMENT

DESCRIPTION

This course domain covers the Introduction to benefit-risk assessment and pharmacoeconomics in decision making, the Principles of pharmacoeconomics and valuation of health states, the Fundamentals of quantitative benefit-risk assessment methods in decision making on medicines and the Advanced quantitative benefit-risk assessment methods in decision making on medicines.

medicines, benefit-risk assessment

Courses offer
available for this domain

Short Courses

Certificates

Master Year 2



OBJECTIVES



ACADEMIC SUPERVISION



avatar

Prof. Olaf Klungel

Academic domain coordinator
Utrecht Universiteit

Utrecht Universiteit

ASSOCIATED PARTNERSHIP

Developed with the Pharma Industry expertise of F. Hoffmann-La Roche Ltd, H. Lundbeck A/S, Janssen Pharmaceutica NV, Laboratorios Almirall SA.

Logo F. Hoffmann-La Roche LtdLogo H. Lundbeck A/SLogo Janssen Pharmaceutica NVLogo Laboratorios Almirall SA

Confused? Read the FAQs...

NEED TO TALK TO US?

+33 5 47 30 42 69

Monday-Friday / 9.00am-6.00pm CET

 

Supported By

IMI logo EU logo efpia logo

Created By

Eu2P Partners